Clinical Trial Update: Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxaliplatin and 5-fluorouracil with or without docetaxel in elderly patients with gastric cancer or adenocarcinoma of the esophagogastr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagogastric Junction
• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• DOCETAXEL (DOCETAXEL)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Krankenhaus Nordwest | Conditions: Gastric Cancer, Adenocarcinoma of the Esophagogastric Junction | Phase 2 | Status: COMPLETED